Concepedia

Paul Leber

PL

13

Publications

1.1K

Citations

12

H-Index

1963

Active since

Affiliations

United States Food and Drug Administration(Current)

Paul Leber is an author at United States Food and Drug Administration specializing in medicine, pharmacology, and health sciences.

Top concepts

MedicinePharmacologyHealthClinical TrialsPharmacotherapyDementiaAddictionNeurologyTreatmentPsychiatry

Publications per year

1963–2000

13

Publications

13

Inactivation of Myosin by 2,4-Dinitrophenol and Protection by Adenosine Triphosphate and Other Phosphate Compounds

Harvey M. Levy, Paul Leber, Elizabeth M. Ryan · Journal of Biological Chemistry · 1963 · 411 citations · Full text

Pharmacology, Adenosine Triphosphate, Biochemistry +1

Hazards of Inference: The Active Control Investigation

Paul Leber · Epilepsia · 1989 · 142 citations

Threats to the Validity of Clinical Trials Employing Enrichment Strategies for Sample Selection

Paul Leber, Charles S. Davis · Controlled Clinical Trials · 1998 · 104 citations

Meta-analysis, Selection Bias, Clinical Trial Management +12

Slowing the progression of Alzheimer disease: methodologic issues.

Paul Leber · PubMed · 1997 · 98 citations

Aging, New Drug, Randomized Start Design +18

Observations and Suggestions on Antidementia Drug Development

Paul Leber · Alzheimer Disease & Associated Disorders · 1996 · 86 citations

Rows per page

1–5 of 13